[This Week's IPO] September Fourth Week Demand Forecast and Subscription Schedule

In the fourth week of this month (September), Hancem, Inspion, Selbion, YJ Link, Lumir, and Three Billion will conduct demand forecasting for institutional investors.

◆Hancem= Hancem is a company established in October 1999, primarily engaged in the development and manufacturing of advanced carbon compound materials. For about 25 years since its founding, it has been producing carbon compounds such as OLED materials, catalyst materials, semiconductor and pharmaceutical materials through CRO and CDMO methods, actively collaborating with leading domestic and international source material companies.

In this IPO, 1.6 million shares will be offered entirely as new shares. The desired offering price is between 12,500 and 14,500 KRW per share, with a total offering amount of 20 billion to 23.2 billion KRW. The demand forecasting will be conducted from the 23rd to the 27th, followed by general subscription on October 7th and 8th, aiming for a KOSDAQ listing within October. Shinyoung Securities is the lead underwriter.

◆Inspion= Inspion is an IT infrastructure specialized company that develops and supplies EAI consulting and security solutions. As large corporations and public institutions become more advanced, the demand for system construction and consulting to improve work efficiency is increasing, and Inspion has been expanding its business focusing on this area.

There are a total of 2.25 million shares, with a desired offering price range of 8,000 to 10,000 KRW per share, and a total offering amount of 18 billion to 22.5 billion KRW. The offering price will be finalized through institutional demand forecasting from the 23rd to the 27th, followed by general subscription over two days on the 7th and 8th. Korea Investment & Securities is the lead underwriter.

◆Selbion= Established in 2010, Selbion is engaged in the development of radiopharmaceutical therapeutic and diagnostic agents, as well as the production of radiopharmaceuticals. The company has established a systematic new drug development and production system through its GMP (Good Manufacturing Practice) manufacturing facility at its Seoul headquarters and its research center in Bundang.

The total number of shares offered is 1,911,000, with a desired offering price per share of 10,000 to 12,200 KRW. Institutional investor demand forecasting will be conducted over five business days from the 24th to the 30th to finalize the offering price, followed by general subscription on the 7th and 8th. The company aims to list in October, with Daishin Securities as the lead underwriter.

◆YJ Link= Founded in 2009, YJ Link is a specialized company in SMT (Surface Mount Technology) process equipment, developing, manufacturing, and selling smart equipment covering the entire SMT process. The SMT process involves attaching SMT components or SMD (Surface Mount Device) components to PCBs (Printed Circuit Boards) to create PCB assemblies.

The total number of shares offered is 3.56 million, with a desired offering price range of 8,600 to 9,800 KRW per share. Institutional demand forecasting will be conducted from the 25th to October 2nd to finalize the offering price, followed by subscription on October 10th and 11th. The company plans to list in October, with KB Securities as the lead underwriter.

◆Lumir= Lumir is a company specializing in earth observation satellite technology development. It has secured a strong position in the satellite market by winning the entire contract for the Synthetic Aperture Radar (SAR) mission payload of the 5th next-generation medium-sized satellite. Through this, it has gained high trust from the government and the Korea Aerospace Research Institute (KARI), playing an important role in the domestic space industry.

In this IPO, a total of 3 million shares will be offered, with a desired offering price band of 16,500 to 20,500 KRW per share, amounting to a total offering of 49.5 billion to 61.5 billion KRW. Demand forecasting for domestic and foreign institutional investors will be conducted over five days from the 26th to October 4th, followed by general investor subscription on October 10th and 11th, aiming for a listing in the second half of the year. NH Investment & Securities is the lead underwriter.

◆Three Billion= The core technology of Three Billion is AI (Artificial Intelligence), which has completed an AI rare genetic disease diagnostic testing platform that interprets the pathogenicity of 100,000 genetic variants per patient with 99.4% accuracy within 5 minutes and identifies the top-5 causative genetic variants of a patient's disease with 98.1% accuracy. Based on this technology, the company operates rare genetic disease diagnostic testing, specific disease diagnostic testing support, data-based diagnostic testing, and SaaS-type software subscription services.

A total of 3.2 million shares will be offered. The expected offering price is between 4,500 and 6,500 KRW, with an expected offering amount of 14.4 billion to 20.8 billion KRW. Demand forecasting will be conducted over five business days from the 27th to October 4th, followed by subscription on October 11th and 14th, with plans to list on the KOSDAQ market within October. Korea Investment & Securities is the lead underwriter.